Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Sutetinib Maleate Capsule in locally advanced or metastatic non-small cell lung cancer is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutetinib Maleate Capsule (sutetinib maleate)

Snippet

Sponsor: Teligene US | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING